What is the Mechanism for Blood Clotting in COVID-19? – European Medical Group
THROMBOSIS is a significant contributor to morbidity and mortality in coronavirus disease-2019 (COVID-19), and researchers may have identified the…
Related Articles
Interview: Pier Mannuccio Mannucci
I think the beginning was when I graduated in the 1960s; my thesis was on red cell enzymes within haematology, but it had nothing to…
EMJ Hematology 12 [Supplement 1] 2024
Welcome to our supplement providing an excellent review of the European Association for Haemophilia and Allied Disorders (EAHAD)…
Equal Access to Haematological Diagnostics
Elizabeth Macintyre discusses her EHA presidency, and the importance of equal access to diagnostics in haematology.
Horizons in Haematology: Insights from the EHA President
António Almeida discusses the three pillars of EHA, modern medical education, and promising treatment advances
Allogeneic Haematopoietic Stem Cell Transplants and Acute Myeloid Leukaemia
Allogeneic haematopoietic stem cell transplant remains the preferred curative approach for treating acute myeloid leukaemia in adults…
EMJ 8.3 2023
We are delighted to share the latest issue of EMJ, our flagship journal, which features content spanning several therapy areas…
Infographic: Sickle Cell Disease
This infographic gives informative statistics and explores the current prevalence of sickle cell disease globally, it also provides…
Sickle Cell Spotlight: Advancements in Treatment and Care
Sophie Lanzkron joins Jonathan to discuss advancements in the treatment of sickle cell disease and how this affects quality of life.
Disparities in Anaemia as a Global Health Problem
Research has emerged highlighting that females are impacted by anaemia to a greater degree than males. Read for more.
Direct Oral Anticoagulants Lower Venous Thromboembolism Recurrence Risk
A lower risk of VTE recurrence and major bleeds has been linked to direct oral anticoagulants for cancer-associated thrombosis.